Trump, rescheduling, and the future of cannabis: chaos, risk, and opportunity as operators navigate federal change, markets, ...

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe ...

Today, the World Anti-Doping Agency (WADA) publishes the 2026 List of Prohibited Substances and Methods (List), which was ...

Ladies and gentlemen, greetings, and welcome to MBX Biosciences Conference Call. Today's call is being recorded. [Operator Instructions] As a reminder, this conference is being recorded. It is now my ...

VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 ...

Ultragenyx Pharmaceutical Inc. ( NASDAQ: RARE) Bank of America Global Healthcare Conference 2025 September 23, 2025 6:35 AM ...

On Wednesday, the World Anti-Doping Agency (WADA) released its list of prohibted substances and methods for 2026.

Objective Youth with childhood-onset SLE (cSLE) have increased risk of serious infection. It is unknown how much of this risk ...

Medically reviewed by Femi Aremu, PharmD Key Takeaways While both contain semaglutide, Wegovy is approved specifically for weight management, whereas Ozempic is approved for the treatment of type 2 ...

The September 17 meeting of the Manitoulin Health Centre (MHC) Mindemoya Auxiliary was highlighted by a $14,000 donation from the auxiliary to the MHC Smart Infusion Pump. “On behalf of the Manitoulin ...